Company page

Satellos Bioscience Inc

Satellos Bioscience Inc, trading under the ticker MSCL, is a public company based in Canada with a market capitalization of approximately CAD 119.8 million. The company focuses on developing innovative therapies for muscle diseases. Satellos aims to address unmet medical needs in the field of muscle health through its proprietary technologies.

profileMSCL:TSXAI content: aiUpdated June 24, 2026/company/satellos-bioscience-inc/c-g5oft7bs
Satellos Bioscience Inc logo
Ticker
MSCL:TSX
Asset type
Stock
Market cap
$119.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TSX
Currency
CAD